Company: BDRX
Filing Date: 2025-11-17
Form Type: F-1
Source: 0001214659-25-016821
Chunk: 171

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-11-17
Form: F-1
Chunk 171
---
 the SEC on May 28, 2024).                                                                                                                                                                                                                                                  |

| II-7 |

| 4.16   
 4.17   |     | Form of Warrant Agent Warrant (incorporated by reference to Exhibit 4.3 of the Company’s Report on Form 6-K, filed with the SEC on May 28, 2024).                                                                                                                                           
 Form of Series J Warrant (incorporated by reference to Exhibit 4.1 of the Company’s Report on Form 6-K, filed with the SEC on July 19, 2024).                                                                                                                                               |
|:-------|:----|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 4.18   |     | Form of July 2024 Placement Agent Warrant (incorporated by reference to Exhibit 4.3 of the Company’s Report on Form 6-K, filed with the SEC on July 19, 2024).                                                                                                                              |
| 4.19   |     | Form of Pre-Funded Warrant  (incorporated by reference to Exhibit 4.4 of the Company’s Report on Form 6-K, filed with the SEC on July 19, 2024).                                                                                                                                            |
| 5.1*   |     | Opinion of Stephenson Harwood LLP.                                                                                                                                                                                                                                                          |
| 5.2*   |     | Opinion of Mintz, Levin, Cohn, Ferris, Glovsky & Popeo, P.C.                                                                                                                                                                                                                                |
| 10.1

#  |     | Biodexa PLC Enterprise Management Incentive and Unapproved Share Option Scheme (incorporated by reference to Exhibit 4.1 to the Company’s Annual Report on Form 20-F for the year ended December 31, 2023, filed with the SEC on April 19, 2024).                                           |
| 10.2

#  |     | Form of Option Agreement (included in Exhibit 10.1).                                                                                                                                                                                                                                        |
| 10.3

#  |     | Form of Appointment Letter between Midatech Pharma PLC and certain directors of Midatech Pharma PLC (incorporated by reference to Exhibit 10.22 to the Company’s Registration Statement on Form F-4 (File No. 333-206305), originally filed with the SEC on August 11, 2015, as amended).   |
| 10.4

#  |     | Deed of